In case you haven’t already, check out Biocept on our other social media platforms! #GetCancerAnswers LinkedIn: linkedin.com/company/Biocept Facebook: facebook.com/biocept Instagram: instagram.com/mybiocept

The San Diego forecast last week was 100% chance of ugly sweater weather. Everyone looked snow good!

We’re simply having a wonderful festive thyme! Thanks to all those who made our space feel jolly during our holiday workplace decorating contest and congratulations to our winners! (Part 3)

We’re simply having a wonderful festive thyme! Thanks to all those who made our space feel jolly during our holiday workplace decorating contest and congratulations to our winners! (Part 2)

We’re simply having a wonderful festive thyme! Thanks to all those who made our space feel jolly during our holiday workplace decorating contest and congratulations to our winners! (Part 1)

Happy Holidays from the Biocept team! We wish you and your family all the best this holiday season and upcoming year! #CNSide #GetCancerAnswers

“When you’re diagnosed with a brain tumor, it’s not just a chapter in your life.” – Dan Zappa Together, let’s continue to invest in hope for patients with LM and brain tumors. Visit abta.org/hope to donate this holiday season. @theABTA #GetCancerAnswers

For more information on how to order CNSide™ Next-Generation Sequencing testing on cerebrospinal fluid, please visit biocept.com/order-a-test.

Today is #GivingTuesday. Together, let’s invest in hope for patients with leptomeningeal metastasis and brain tumors. In the spirit of holiday giving, donate now to @theABTA: bit.ly/2022GTSocial #GetCancerAnswers

Visit Biocept’s booth (#512) at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology and learn about the clinical poster on mutant p53 positive glioblastoma cells being presented on Friday, 11/18 from 7:30-9:30 PM ET. #CNSide #GetCancerAnswers #SNO2022

Visit Biocept’s booth (#512) at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology and learn about the PPTID clinical poster being presented on Friday, 11/18 from 7:30-9:30 PM ET. @NeuroOnc #CNSide #GetCancerAnswers #SNO2022

Visit Biocept’s booth (#512) at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology and learn about the HER2 Flip clinical poster being presented on Friday, 11/18 from 7:30-9:30 PM ET. @NeuroOnc #GetCancerAnswers #SNO2022

#FlashbackFriday to our Biocept luncheon with @Duffsdoggz to celebrate the @Padres advancing in the playoffs! Let’s go Padres!

#InTheNews: Biocept Expands Commercial Offering of CNSide™ Assay to Most Cancers that Metastasize to the Central Nervous System Learn more: ir.biocept.com/news-releases… #CNSide #GetCancerAnswers

Join our CNSide webinar on October 14th at 1:00pm ET, featuring key opinion leaders Priya U. Kumthekar, MD and Seema A. Nagpal, MD. Register here: event.choruscall.com/mediafr… #CNSide #GetCancerAnswers

Did you know? Biocept initiated a clinical trial, the FORESEE Study, for patients with breast or non-small cell lung cancer (NSCLC) who have suspected or confirmed leptomeningeal metastases (LM). Learn more: biocept.com/clinical-trials/ #CNSide #GetCancerAnswers #FORESEEStudy

Science and creativity go hand in hand. It’s no surprise our Biocept team can paint like Van Gogh. 😊 #teambuilding #ThrowbackThursday

Today is Stand Up To Cancer Day. Join us in bringing awareness. We’re stronger together. #StandUpToCancer #GetCancerAnswers #CNSide

#IntheNews: Plus Therapeutics Awarded $17.6 Million from State of Texas. The funding will support the ReSPECT-LM Study and development of Rhenium-186 NanoLiposome (186RNL) for leptomeningeal metastases. Learn more on @plustxinc: ir.plustherapeutics.com/news… #ClinicalTrial #CNSide

We had a fantastic time engaging with the neuro-oncology community again at the 2022 Annual Conference on CNS Clinical Trial and Brain Metastases and exploring the city of Toronto! Thank you again to @NeuroOnc and @ASCO for hosting. #GetCancerAnswers #CNSide #brainmets